Senzime AB (publ), a medical device company, develops and markets patient monitoring systems to monitor patients under anesthesia in Europe, Oceania, Asia, Canada, and the United States. The company offers TetraGraph, a monitor that stimulates, measures, analyzes, and displays muscle function in surgical patients receiving neuromuscular blocking agents; TetraSens electrode array, which has two proximal stimulating electrodes for recording and reference; TetraConnect, a data management portal that helps clinician to access, view, and export data records from the TetraGraph in PDF or Excel format; TetraGraph Device Connectivity, which transfers data from the TetraGraph Monitor to patient monitoring systems; and TetraGraph Philips Interface that enables the transmission of neuromuscular monitoring parameters, TOFC, TOFR, PTC, and TOF bars to Philips patient monitors, as well as TetraGraph readings are displayed on the Philips Intellivue Monitor. It also develops CliniSenz Analyzer for postoperative and continuous patient monitoring in hospital environments; and Onzurf Probe, a sterile CE-marked single use product based on micro-dialysis technology that enables continuous sampling from gastro-intestinal organs, such as esophagus, stomach, and liver. Senzime AB (publ) has a strategic license and connectivity agreement with Masimo to develop and market the TetraGraph Smart Cable Module that connects directly to Root monitoring system, as well as to their digital hubs to interface with the hospital clinical information system/electronic health records. The company was incorporated in 1999 and is based in Uppsala, Sweden.

Senzime AB (publ)

Timik Group is a Nordic healthcare company that focuses on medical equipment for diagnosing, treating and management of acute and chronic diseases.

Timik Group

Senzime is a global medical device company that provides precision-based patient monitoring solutions to safeguard patient care from anesthesia to recovery.

Metric
Company Name	Senzime AB (publ)	Timik Group
Symbol	SEZI
MSH ID	COM:SENZIME	COM:TIMIKGROUP
Market	STOCKS	PRIVATE
Sector	Healthcare	Healthcare & Health Services
Industry	Medical - Devices	Medical Equipment
Country	SE	SE
Stage
Employee Count	52
Website	senzime.com	timikgroup.com
LinkedIn		timik-group-ab
Founders

Metric
Market Cap	67.21M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	3.27M
Revenue (LTM)
Revenue (NTM)
Gross Profit	704.86K
EBITDA	-10.64M
Operating Income	-12.24M
Net Income	-12.27M
EPS	-0.13
Diluted EPS	-0.13
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.29
Operating Profit Margin	-2.82
EBITDA Margin	-3.25
Net Profit Margin	-2.77
Return on Equity	-0.38
Return on Assets	-0.31
Return on Capital Employed	-0.32

SEZI

COM:SENZIME

Senzime

Last Close

5.71

25/11 09:38

Market Cap

734.32M

Beta: -

Volume Today

60.04K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-6.16
P/B Ratio	2.31
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	22.38
EV Multiple	-5.75

Metric
Days Sales Outstanding
Days Payables Outstanding	59.56
Days Inventory Outstanding	279.14
Operating Cycle	409.69
Cash Conversion Cycle	341.68
Asset Turnover	0.12

Metric
Operating Cash Flow	-10.42M
Free Cash Flow	-11.14M
Cash Flow to Debt	-4.69
Operating Cash Flow/Sales	-2.40
Free Cash Flow Yield	-0.16

Metric
Cash & Equivalents	13.82M
Accounts Receivable	-452.80K
Inventory	1.86M
Goodwill
Debt to Capitalization	0.07
Debt to Assets	0.03
Current Ratio	4.79
Quick Ratio	6.98

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue	0.71
SG&A to Revenue	1.48